Generation Bio Co. GBIO
5.34 USD 0.00 (+0.00%)
Feb 10, 2026, 9:30 AM EST
5.34 Day range 5.34
52-week range unavailable
- YTD
- -5.99%
- 1 year
- -23.71%
Analyst view
Price target (mean) 7.50 +40.4% upside
Now 5.34
- Target (low)
- 5.00
- Target (mean)
- 7.50
- Target (high)
- 10.00
Ratings (0m) 7 4 buy · 3 hold · 0 sell
- Strong buy1
- Buy3
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.22546 | -0.27 – -0.18092 | -0.53 | +57.5% | 2.92M | +1.4% | 2 |
| Next quarter | -0.31 | -0.31 – -0.31 | -0.2651 | -16.9% | 1.40M | -65.5% | 1 |
| Current year | -1.81 | -1.88 – -1.75 | -1.96 | +7.4% | 18.14M | +207.2% | 2 |
| Next year | -0.66123 | -1.01 – -0.31246 | -1.81 | +63.6% | 7.11M | -60.8% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2024 | Needham | Reiterated | Buy | Buy |
| Aug 8, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 8, 2024 | Needham | Reiterated | Buy | Buy |
| May 14, 2024 | Needham | Reiterated | Buy | Buy |
| May 14, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Apr 10, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 7, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 7, 2024 | Needham | Maintained | Buy | Buy |
| Nov 10, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Oct 23, 2023 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Oct 19, 2023 | TD Cowen | Downgrade | Outperform | Market Perform |
| Aug 16, 2023 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 3, 2023 | Needham | Reiterated | — | Buy |
| Aug 3, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| May 11, 2023 | Needham | Reiterated | Buy | Buy |
| Apr 19, 2023 | Needham | Reiterated | — | Buy |
| Mar 24, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Mar 23, 2023 | Needham | Reiterated | — | Buy |
| Mar 6, 2023 | JMP Securities | Maintained | — | Market Outperform |
| Feb 24, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Feb 24, 2023 | Needham | Maintained | — | Buy |
| Jan 19, 2023 | JMP Securities | Maintained | — | Market Outperform |
| Nov 8, 2022 | Canaccord Genuity | Initiated | — | Buy |
| Aug 8, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Aug 5, 2022 | Needham | Maintained | — | Buy |
| Dec 15, 2021 | JMP Securities | Maintained | — | Market Outperform |
| Dec 15, 2021 | Needham | Maintained | — | Buy |
| Dec 14, 2021 | Wedbush | Maintained | Outperform | Outperform |
| Jul 14, 2021 | Wedbush | Maintained | Outperform | Outperform |
| Jun 8, 2021 | JMP Securities | Initiated | — | Market Outperform |